On a magic taxi ride. Well, you don't know what we can see. Why don't you tell your dreams to me. Fantasy will set you free...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The one drawback though is that a Salsa Music Fest, though it could be huge in the Miami, would be unlikely to help $IMTV build on the nationwide notoriety they received through LIT Up Fest. The nice thing about having worked with Tekashi69 is his antics are equivalent to free nationwide press attention.
IMTV has a good 2 months now to prep for the best concert yet.
This nice close here is a good indicator for the rest of the week. I think we'll see a strong open tommorow for $GTBP.
Nice green close for GTBP.
You know what this is? Basically its a non dilutive recipe to squeeze $IMTV right up into pennyland ASAP: "Additionally, management is pleased to announce that IMTV has reached written agreements with its existing convertible note holders holding free trading shares, negotiating terms of stock sales for a period of 1-year, effective immediately that now prohibit stock sales of less than $.004 and further prohibit stock sales of more than $30,000 in any single month without prior written approval from Management, during the 1-year term. Management wants to thank IMTV debt holders for working with the Company and assisting its efforts to clean up the Company's cap structure."
Once again, this is $IMTV demonstrating that they have shareholders best interests at heart. How many sub penny's would even address this kind of concern from stock holders? "Shareholders have expressed concern regarding an increase in our issued and outstanding share count, by roughly 600 million shares, between July 20, 2018 and July 25, 2018. These shares were part of a note negotiated by prior management in 2014. As part of our continued effort to clean up the cap structure and debt of IMTV, we arranged for the original note holder to sell their note to another investor, which other investor then sold 3 pieces of the 2014 note they acquired to three other companies. All 4 companies holding a piece of the original note have expressed a strong vested interest in seeing IMTV succeed"
Great Update: "Imagination TV, Inc. ("IMTV, "we" or "us"), is pleased to announce that it has successfully completed its second event, LIT Up Music Festival and is hard at work planning its next event. The company has recently reported its first revenues of $130,013 (Q2 2018 financials available at otcmarkets.com). Additionally, we have controlled operating costs, and we successfully re-worked and retired toxic debt that otherwise could have resulted in as much as 13 billion shares coming into the market. "
Wow, closing up almost at HOD day of 18!
$GTBP is looking strong again. I'm expecting we'll hear more about phase 2 of OXS 1550 soon.
Agreed I wouldnt be surprised with a new push up this week. Especially with some news.
If we make it that long without a buyout. Would be huge.
We could be getting big news on OXS 1550 and finalization of Phase 2 results.
Don't quote me on this, but I see all the signs that this is getting read for a epic run. Lots of rumbling from quietly accumulating whales to be discerned if you look at it.
They're heavy hitters in the biopharma world. These guys know how to work an end game startegy that is really sweet for the shareholders.
Quite impressive!
$GTBP BUSINESS DESCRIPTION: We are a clinical stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products and a portfolio of central nervous system, or CNS, product candidates. Our immuno-oncology portfolio is based off a proprietary technology platform consisting of single-chain bi-, tri- and tetra-specific scFv constructs, combined with proprietary antibody-drug linkers and drug payloads. Our CNS portfolio consists of innovative reformulations and/or repurposing of existing therapies that are covered by issued or filed composition of matter patents.
Meanwhile the $2 support stands strong as ever.
Fascinating they both attack leukemia but from different angles. The possibilities of Immuno Oncology therapies are endless truly.
Huge Upside on This: OXS-1550 "is a bispecific scFv recombinant fusion protein-drug conjugate composed of the variable regions of the heavy and light chains of anti-CD19 and anti-CD22 antibodies and a modified form of diphtheria toxin as its cytotoxic drug payload. CD19 is a membrane glycoprotein present on the surface of all stages of B-lymphocyte development, and is also expressed on most B-cell mature lymphoma cells and leukemia cells. CD22 is a glycoprotein expressed on B-lineage lymphoid precursors, including precursor acute lymphoblastic leukemia, and often is co-expressed with CD19 on mature B-cell malignancies such as lymphoma.
OXS-1550 targets cancer cells expressing the CD19 receptor or CD22 receptor or both receptors. When OXS-1550 binds to cancer cells, the cancer cells internalize OXS-1550, and are killed due to the action of drug’s cytotoxic diphtheria toxin payload. OXS-1550 has demonstrated success in a Phase 1 human clinical trial in patients with relapsed/refractory B-cell lymphoma or leukemia."
This churning at $2 is a indicator of a bump up to some. We are now shaking out the limp wristed hands before we pop up towards $3 again. Some news would be big.
OXS 1550 IMHO (though I have no public confirmation) is currently a buyout target of a mega multibillion dollar biopharma to work as a complimentarian therapy with an established highly lucrative existing cancer drug (hence the now publicaly disclosed new round of testing the two thereapies side by side. This is massive and would vindicate the uplisting hits we've been getting in PR's and the restructuring of the exec team for an uplisting event. Do I need to tell you how huge this would be for IMTV holders? Just stitching together the pieces we do have.... you need to do your own DD.
Once again we see the rock solid support $GTBP has at 2. Shorty is barking up the wrong tree here.
OXS 3550 is $GTBP's most advanced tri specific therapy and it will utterly shatter the current paradigm for successful treatment of solid tumors.
I would not be surprised if big news on OXS 1550 was released soon and we saw some big momo soon.
Fascinating developments.
GT Biopharma, Inc. a targeted immunotherapies company with close to market treatments for Central Nervous System diseases.
IMMUNOTHERAPY FOR THE TREATMENT OF CANCER
Using our proprietary platform technology, GT Biopharma is generating novel immuno-oncology biopharmaceutical drugs targeting cancers such as acute lymphocytic leukemia, non-Hodgkin's lymphoma, acute myeloid leukemia and multiple solid tumors.
Are you new to GTBP? Heres a good place to start your DD: https://www.gtbiopharma.com/
The GTBP therapy technology is the stuff of the future. Amazing developments.
Yeah, the old chemotherapy model of cancer treatment is liking poisoning the whole lawn to kill the dandelions. It saves lives, but also messes patients up.
Yeah in fact the patient was taking their daily jog around the lake for excercise while receiving the OXS 1550 therapy. Try doing that while receiving chemotherapy for lyphoma! aint gonna happen. $GTBP
This therapy pipeline would utterly revolutionize cancer treatment if it gets FDA approved and brought to market IMO. The early testing results are very promising.
Fascinating background info.
Great for $GTBP to park today over $2 again. Churning here and accumulating for the next pop.
GTBP standing strong over that $2 support.
If we get some kind of buyout of IP from this colloboration regarding OXS1550 we should be in prime position to make a run at uplisting for $GTBP.
Immuno oncology are like smart bombs that can deliver payloads directly to the cancer only. The benefits to the patient are obvious. $GTBP is on the right track.
Traditional chemotherapy can be effective but it works by poisoning the whole garden to get to a few weeds.
GTBP OXS 3550 could be even more revolutionary. Will revolutionize solid tumor treatment.
LOL, I don't think shorty is very happy today. I heard so many predictions of this going down as low as 1.4 but $2 is a solid support. Running for cover!